DNA methylation in endometriosis (Review)

Area of Science:

• Gynecology
• Epigenetics
• Molecular Biology

Background:

• Endometriosis involves endometrial tissue growth outside the uterus, exhibiting benign yet malignant-like characteristics.
• Epigenetic aberrations, particularly DNA methylation, are increasingly recognized as crucial in endometriosis development.
• This disease involves aberrant hormonal, immunological, and inflammatory processes.

Purpose of the Study:

• To review the current literature on DNA methylation's role in endometriosis pathophysiology and malignant progression.
• To explore the potential of DNA methylation-modifying agents as future pharmaceutical treatments for endometriosis.

Main Methods:

• Literature review of studies investigating DNA methylation in endometriosis.
• Analysis of molecular techniques elucidating the association between DNA methylation and gene expression.
• Examination of evidence linking epigenetic deregulations to hormonal and environmental factors.

Main Results:

• Aberrant DNA methylation is a key mechanism linking gene expression changes to endometriosis.
• Evidence suggests extrinsic factors influence epigenetic deregulation in endometriosis.
• Variations in epigenetic patterns of relevant genes have been reported.

Conclusions:

• DNA methylation plays a significant role in the pathophysiology and malignant evolution of endometriosis.
• The causal relationship between molecular changes and endometriosis requires further investigation.
• DNA methylation-modifying agents represent a promising avenue for endometriosis pharmaceutical research.